Researchers Can Grow Functional Stomach and Intestinal Tissues to Study Diseases, New Drugs
Scientists report in Nature using pluripotent stem cells to generate human stomach tissues in a petri dish that produce acid and digestive enzymes.
Publishing their findings online Jan. 4, researchers at Cincinnati Children’s Hospital Medical Center grew tissues from the stomach’s corpus/fundus region. The study comes two years after the same team generated the stomach’s hormone-producing region (the antrum).
The discovery means investigators now can grow both parts of the human stomach to study disease, model new treatments and understand human development and health in ways never before possible.
“Now that we can grow both antral- and corpus/fundic-type human gastric mini-organs, it’s possible to study how these human gastric tissues interact physiologically, respond differently to infection, injury and react to pharmacologic treatments,” said Jim Wells, PhD, principal investigator and director of the Pluripotent Stem Cell Facility at Cincinnati Children’s. “Diseases of the stomach impact millions of people in the United States and gastric cancer is the third leading cause of cancer-related deaths worldwide.”
The current study caps a series of discoveries since 2010 in which research teams led or co-led by Wells used human pluripotent stem cells (hPSC) – which can become any cell type in the body – to engineer regions of the human stomach and intestines. They are using the tissues to identify causes and treatments for diseases of the human gastrointestinal tract.
This includes a study published Nov. 21, 2016 by Nature Medicine, in which scientists generated human intestine with an enteric nervous system. These highly functional tissues are able to absorb nutrients and demonstrate peristalsis, the intestinal muscular contractions that move food from one end of the GI tract to the other.
The primary focus of Wells’ laboratory is to study how organs form during embryonic development. This includes the esophagus, stomach, pancreas and intestines. Wells and his colleagues have a particular interest in finding new treatments for genetic forms of diseases like monogenic diabetes and Hirschsprung’s disease.
Starting from Scratch
A major challenge investigators encountered in the current study is a lack of basic knowledge on how the stomach normally forms during embryonic development.
“We couldn’t engineer human stomach tissue in a petri dish until we first identified how the stomach normally forms in the embryo,” explains Wells.
To fill that gap, the researchers used mice to study the genetics behind embryonic development of the stomach.
In doing so, they discovered that a fundamental genetic pathway (WNT/?-catenin) plays an essential role in directing development of the corpus/fundus region of the stomach in mouse embryos. After this, researchers manipulated the WNT/?-catenin in a petri dish to trigger the formation of human fundus organoids from pluripotent stem cells.
Study authors then further refined the process, identifying additional molecular signaling pathways that drive formation of critical stomach cell types of the fundus. These include chief cells, which produce a key digestive enzyme called pepsin, and parietal cells. Parietal cells secrete hydrochloric acid for digestion and intrinsic factor to help the intestines absorb vitamin B-12, which is critical for making blood cells and maintaining a healthy nervous system.
Wells said that it takes about six weeks for stem cells to form gastric-fundus tissues in a petri dish.
Translational Direction
Researchers now plan to study the ability of tissue-engineered human stomach organoids to model human gastric diseases by transplanting them into mouse models. In particular, Wells and his collaborator Yana Zavros, PhD, associate professor at the University of Cincinnati, want to explore how the fundus organoids respond after being infected with H (Helicobacter) pylori bacteria. H pylori causes chronic gastritis, stomach ulcers and is a major risk factor for the development of stomach cancer.
Stomach organoids can also be used in combination with intestinal organoids to study how the body controls digestion and proper nutrient uptake, as well as a variety of other medical conditions affecting the gastrointestinal tract. These include gastrointestinal motility disorders, inflammatory diseases, drug uptake studies, and studying helpful microbes (probiotics) as well as harmful ones.
Learn more: Scientists Tissue-Engineer Part of Human Stomach in Laboratory
[osd_subscribe categories=’tissue-engineering’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “TISSUE ENGINEERING”‘]
Receive an email update when we add a new TISSUE ENGINEERING article.
The Latest on: Tissue engineering
[google_news title=”” keyword=”tissue engineering” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tissue engineering
- Ohio company gets greenlight from FDA to test Cuban drug for diabetic ulcerson May 1, 2024 at 2:55 pm
It works by activating a receptor on the surface of cells that stimulates them to grow, migrate where they are needed, and differentiate into the different cell types in wound healing such as those ...
- How a Controversial Cryonics Procedure Could Finally Make Immortality Possibleon May 1, 2024 at 10:53 am
Futurists, including some medical doctors, are signing up to be decapitated—and then have their brains frozen. But without a body, what will their minds become?
- Hot or not: A new device for treating temperature-related emergencieson May 1, 2024 at 8:12 am
We thought that together our team had the right skills and background to develop a worthwhile solution and saw this as a cool opportunity to introduce a new technology for EMS providers so they can ...
- Engineered living materials: Scientists 3D print with bio-ink made from tobacco cellson May 1, 2024 at 5:21 am
Using a 3D printer and a bioink, scientists create an "engineered plant living material" (EPLM) that harnesses the power of cells.
- First fetus-to-fetus transplant in rats produces functional kidneyson May 1, 2024 at 3:49 am
The research, conducted in Japan, represents the first instance of organ and tissue transplants conducted in utero.
- Two UTA faculty honored for outstanding researchon April 30, 2024 at 11:50 am
The University of Texas at Arlington is honoring two faculty for their outstanding contributions to research.
- Biocompatible Polymers Market Poised for Explosive Growth: Reaching US$ 1.8 Billion by 2033on April 30, 2024 at 1:27 am
In 2023, the biocompatible polymers market is expected to be worth US$ 957 million. The market is expected to reach US$ 1,847.7 million by 2033, expanding at a 6.8% CAGR throughout the forecast period ...
- 3D Cell Culture Marketon April 28, 2024 at 10:16 pm
D Cell Culture Market an astounding US$ 3 billion by 2033, This trajectory represents a robust Compound Annual Growth Rate (CAGR) of 9%.
- New experimental evidence unlocks a puzzle in vascular tissue engineeringon April 25, 2024 at 9:25 am
Angiogenesis is a process of forming hierarchical vascular networks in living tissues. Its complexity makes the controlled generation of blood vessels in laboratory conditions a highly challenging ...
via Bing News